Myriad Genetics Inc (MYGN)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	-127,300	-116,000	-155,200	-234,600	-263,300	-274,400	-248,200	-146,200	-112,000	-77,300	-17,600	-8,200	-27,200	-63,800	-103,600	-154,300	-230,000	-194,100	-199,500	-148,300
Revenue (ttm)	US$ in thousands	837,600	823,600	802,200	774,200	753,200	734,400	698,900	694,700	678,400	661,400	672,300	682,400	690,600	684,400	662,300	566,100	557,000	597,500	638,600	760,800
Net profit margin		-15.20%	-14.08%	-19.35%	-30.30%	-34.96%	-37.36%	-35.51%	-21.05%	-16.51%	-11.69%	-2.62%	-1.20%	-3.94%	-9.32%	-15.64%	-27.26%	-41.29%	-32.49%	-31.24%	-19.49%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-127,300K ÷ $837,600K
= -15.20%

Myriad Genetics Inc has experienced fluctuating net profit margins over the past few years, as seen from the provided data. The net profit margin, a key indicator of profitability, represents the percentage of revenue that translates into net income after accounting for all expenses.

The net profit margins started at a negative level in March 2020 and continued to decline until December 2021, reaching a low of -41.29%. This indicates that during this period, the company's expenses outweighed its revenue, resulting in overall negative profitability.

However, there was a gradual improvement in the net profit margin from March 2022 to December 2024. Although the margins remained negative, they shifted towards a less negative range, suggesting that the company may have been able to better control its expenses or increase revenue streams during this time.

The latest reported net profit margin of -15.20% in December 2024 indicates that the company is still facing challenges in generating significant profits relative to its revenue. Continued monitoring and strategic adjustments may be required to further enhance profitability in the future.